Patents Assigned to ACUCORT AB
  • Dexamethasone oral film
    Patent number: 11083734
    Abstract: The present invention relates to an oral film consisting essentially of dexamethasone and hydroxypropyl methylcellulose, wherein the concentration of dexamethasone is 30% w/w or more and the concentration of hydroxypropyl methylcellulose is between 35 and 70% w/w based on total dry matter.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: August 10, 2021
    Assignees: ACUCORT AB, LTS LOHMANN THERAPIE-SYSTEME AG
    Inventor: Bengt Arvid Westrin
  • DEXAMETHASONE ORAL FILM
    Publication number: 20190175617
    Abstract: The present invention relates to an oral film consisting essentially of dexamethasone and hydroxypropyl methylcellulose, wherein the concentration of dexamethasone is 30% w/w or more and the concentration of hydroxypropyl methylcellulose is between 35 and 70% w/w based on total dry matter.
    Type: Application
    Filed: December 7, 2018
    Publication date: June 13, 2019
    Applicants: ACUCORT AB, LTS LOHMANN THERAPIE-SYSTEME AG
    Inventor: Bengt Arvid Westrin
  • Pharmaceutical compositions for acute glucocorticoid therapy
    Patent number: 9925139
    Abstract: The present invention relates to glucocorticoid-containing pharmaceutical compositions or kits for use in acute emergency situations where acute glucocorticoid therapy is required. Notably, the invention relates to pharmaceutical compositions and kits that are designed to be administered by non-medically trained persons outside a hospital or another medical or clinical setting. The invention also relates to a method for treating a disorder requiring acute glucocorticoid therapy by providing a fast onset of action of a glucocorticoid.
    Type: Grant
    Filed: April 21, 2005
    Date of Patent: March 27, 2018
    Assignee: ACUCORT AB
    Inventors: Stanko Skrtic, Jörgen Johnsson, Hans Lennernäs, Thomas Hedner, Gudmundur Johannsson
  • DEXAMETHASONE ORAL FILM
    Publication number: 20170304319
    Abstract: The present invention relates to an oral film consisting essentially of dexamethasone and hydroxypropyl methylcellulose, wherein the concentration of dexamethasone is 30% w/w or more and the concentration of hydroxypropyl methylcellulose is between 35 and 70% w/w based on total dry matter.
    Type: Application
    Filed: November 4, 2015
    Publication date: October 26, 2017
    Applicants: ACUCORT AB, LTS LOHMANN THERAPIE-SYSTEME AG
    Inventor: Bengt Arvid WESTRIN